Status:
COMPLETED
NEW MONITORING IN DIFFERENTIAL DIAGNOSIS OF HYPERLACTATHEMIA IN CARDIOPULMONARY BYPASS SURGERY
Lead Sponsor:
Acibadem University
Conditions:
Etiology of Hyperlactathemia
Early Period After Cardiopulmonary Bypass Surgery
Eligibility:
All Genders
43-80 years
Brief Summary
Objective: The objective of the study was to investigate a reverse correlation between blood lactate levels and rSO2, and distinguish between hypoxic and non-hypoxic hyperlactatemia seen in the early ...
Detailed Description
The objective of the prospective study was to investigate a reverse correlation between blood lactate levels and rSO2, and distinguish between hypoxic and non-hypoxic hyperlactatemia seen in the early...
Eligibility Criteria
Inclusion
- ASA) II-III patients, aged 43-80 years, undergoing on-pump coronary artery bypass grafting
Exclusion
- Active congestive cardiac failure, intraoperative death, urgent cardiac surgery or reoperation, hemodynamic instability or need of inotropic support before the operation, the elevation of any parameters preoperatively suggestive of systemic hypoperfusion, coagulopathy, renal failure, hepatic dysfunction, local or systemic infection, and inflammation.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04706884
Start Date
March 1 2018
End Date
March 1 2019
Last Update
January 14 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Acıbadem Mehmet Ali Aydinlar University Atakent Hospital
Istanbul, Atakent, Turkey (Türkiye), 34303
2
Acibadem University
Istanbul, Turkey (Türkiye)